NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)

NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)  Department of Health and Human Services  National Institutes of Health

Purposesupport_cancer_research

The purpose of this funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI), is to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance cancer research in all areas relevant to the mission of the NCI. By using the R21 mechanism, this FOA will support exploratory/developmental projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, and/or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).

Applications for R21 awards should describe projects distinct from those supported through the traditional R01 mechanism. For example, such projects could assess the feasibility of a novel area of investigation or a new experimental system that has the potential to enhance health-related research. Another example could include the unique and innovative use of an existing methodology to explore a new scientific area. Conversely, long-term projects, or projects designed to increase knowledge in a well-established area, should not be submitted as R21 applications.

Applications submitted under this mechanism should break new ground or extend previous discoveries toward new directions or applications. Projects of limited cost or scope that use widely accepted approaches and methods within well-established fields are better suited for the R03 small grant mechanism, which is presently also supported by the NCI Omnibus R03 FOA,PAR-14-007.

Specific Research Objectivescancer research ad2_0

All areas of cancer research relevant to the mission of the NCI are appropriate for projects submitted to this FOA (for a list of extramural research funding programs at the NCI, go tohttp://www.cancer.gov/researchandfunding/extramural). Proposed projects may involve basic, translational, clinical, and/or population research. Examples of relevant areas include but are not limited to studies of: cancer biology; cancer control; cancer diagnosis; cancer disparities; cancer prevention; and cancer treatment.

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-15-340
Funding Opportunity Title: NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
CFDA Number(s): 93.393 — Cancer Cause and Prevention Research
93.394 — Cancer Detection and Diagnosis Research
93.395 — Cancer Treatment Research
93.396 — Cancer Biology Research
93.399 — Cancer Control
Cost Sharing or Matching Requirement: No
Posted Date: Sep 1, 2015
Creation Date: Sep 1, 2015
Original Closing Date for Applications: Nov 10, 2015  
Current Closing Date for Applications: Nov 10, 2015  
Archive Date: Dec 11, 2015
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

ligibility

Eligible Applicants:
City or township governments
Special district governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
For profit organizations other than small businesses
Private institutions of higher education
County governments
Native American tribal governments (Federally recognized)
Independent school districts
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The National Cancer Institute (NCI) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in all areas of cancer research. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-15-340.html
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s